8-K: Organovo Rebrands as VivoSim Labs, Inc., Focusing on 3D Bioprinting
Press Release
Organovo Holdings, Inc. will rebrand as VivoSim Labs, Inc., effective April 24, 2025, and will trade under the new ticker symbol VIVS on the Nasdaq Capital Market.
Summary
- Organovo Holdings, Inc. announced it will be carrying forward its 3D bioprinting and legacy technology under the name VivoSim Labs, Inc.
- The name change is effective April 24, 2025.
- The company's common stock will begin trading on the Nasdaq Capital Market under the new ticker symbol VIVS at market open on April 24, 2025.
- Existing stockholders are not required to take any action regarding the name and ticker symbol change.
- The company's common stock will continue to be listed on the Nasdaq Capital Market, and the CUSIP number (68620A302) will remain unchanged.
Sentiment
Score: 6
Explanation: The announcement is neutral, simply stating a change in name and ticker symbol. The sentiment is slightly positive as it indicates a continuation of the business under a new brand.
Positives
- The rebranding may signal a renewed focus on the company's core 3D bioprinting technology.
- The ticker symbol change could generate renewed investor interest.
Risks
- The press release contains forward-looking statements that are subject to risks and uncertainties detailed in the company's SEC filings, including the Annual Report on Form 10-K and Quarterly Reports on Form 10-Q.
- The company cautions against placing undue reliance on these forward-looking statements.
Future Outlook
The company's future performance is subject to risks and uncertainties detailed in its SEC filings, and investors should not place undue reliance on forward-looking statements.
Industry Context
The 3D bioprinting industry is still in its early stages, and the rebranding may indicate a strategic shift to capitalize on this emerging market.
Stakeholder Impact
- Shareholders will see a change in the company's name and ticker symbol.
- Employees will continue working under the new company name, VivoSim Labs, Inc.
Key Dates
| Date | Description |
|---|---|
| May 31, 2024 | Date of Annual Report on Form 10-K filed with the SEC. |
| February 19, 2025 | Date of most recently filed Quarterly Report on Form 10-Q filed with the SEC. |
| April 23, 2025 | Date of press release announcing the rebranding. |
| April 24, 2025 | Effective date of the name change to VivoSim Labs, Inc. and start of trading under the ticker symbol VIVS. |
Keywords
VivoSim Labs, Organovo, 3D Bioprinting, Ticker Symbol, Rebranding, VIVS, ONVO
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.